{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-017437","form_type":"8-K","ticker":"ACXP","cik":"0001736243","company_name":"Acurx Pharmaceuticals, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.663008+00:00","generated_at":"2026-05-26T03:43:43.797582+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Acurx Pharmaceuticals receives Nasdaq minimum bid price deficiency notice; 180-day cure period","bullets":["Stock closed below $1.00 for 31 consecutive business days, triggering Nasdaq Listing Rule 5550(a)(2) deficiency.","Company has until August 25, 2025 to regain compliance by closing at $1.00 or higher for 10 consecutive business days.","If compliance not met, Company may seek a second 180-day period via a reverse stock split if other listing standards are met.","No immediate effect on listing; stock continues trading on Nasdaq Capital Market under symbol 'ACXP'.","Company intends to monitor bid price and consider available options but can provide no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-017437","json":"https://secwatch.observer/filing/0001104659-25-017437.json","markdown":"https://secwatch.observer/filing/0001104659-25-017437.md","text":"https://secwatch.observer/filing/0001104659-25-017437.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925017437/0001104659-25-017437-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925017437/tm257571d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:43:43.797582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}